Lee Ainslie - Maverick Capital Ltd
Period:    Q1 2026
Portfolio date:    31 Mar 2026
No. of stocks:    239
Portfolio value:    $8,599,101,588
Holdings Activity Buys Sells    History
Holding/activity history for  Edwards Lifesciences Corp. (EW)
Period Shares % of Portfolio Activity % Change to Portfolio Reported Price Value Filing
2024   Q4 0 0.00 Sell 100.00% 0.04 SEC
2024   Q3 29,594 0.04 Buy 0.04 $65.99 $1,952,908 SEC
2024   Q1 0 0.00 Sell 100.00% <0.01 SEC
2023   Q4 2,977 <0.01 Reduce 43.91% <0.01 $76.25 $226,996 SEC
2023   Q3 5,308 0.01 Add 22.93% <0.01 $69.28 $367,738 SEC
2023   Q2 4,318 0.01 Reduce 39.46% <0.01 $94.33 $407,317 SEC
2023   Q1 7,133 0.01 Add 96.94% <0.01 $82.73 $590,113 SEC
2022   Q4 3,622 0.01 Reduce 74.56% 0.02 $74.61 $270,237 SEC
2022   Q3 14,238 0.03 Buy 0.03 $82.60 $1,176,000 SEC
2020   Q4 0 0.00 Sell 100.00% 0.02 SEC
2020   Q3 15,652 0.02 Reduce 48.75% 0.02 $79.80 $1,249,000 SEC
2020   Q2 30,541 0.04 Buy 0.04 $69.12 $2,111,000 SEC
2018   Q4 0 0.00 Sell 100.00% 0.09 SEC
2018   Q3 39,160 0.09 Reduce 61.55% 0.11 $174.11 $6,818,000 SEC
2018   Q2 101,840 0.18 Add 36.13% 0.05 $145.57 $14,825,000 SEC
2018   Q1 74,810 0.14 Reduce 5.85% <0.01 $139.51 $10,437,000 SEC
2017   Q4 79,460 0.12 Add 73.15% 0.05 $112.71 $8,956,000 SEC
2017   Q3 45,890 0.07 Add 36.25% 0.02 $109.30 $5,016,000 SEC
2017   Q2 33,680 0.05 Add 9.03% <0.01 $118.23 $3,982,000 SEC
2017   Q1 30,890 0.04 Reduce 19.64% <0.01 $94.08 $2,906,000 SEC
2016   Q4 38,440 0.05 Add 42.90% 0.02 $93.70 $3,602,000 SEC
2016   Q3 26,900 0.04 Reduce 16.72% <0.01 $120.56 $3,243,000 SEC
2016   Q2 32,300 0.04 Buy 0.04 $99.72 $3,221,000 SEC
2015   Q3 0 0.00 Sell 100.00% <0.01 SEC
2015   Q2 1,960 <0.01 $142.35 $279,000 SEC
2015   Q1 1,960 <0.01 Buy <0.01 $142.35 $279,000 SEC